SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000860655-96-000077
Filing Date
1996-07-26
Accepted
1996-07-26 00:00:00
Documents
1
Group Members
ALBERTO W. VILARAMERINDO ADVISORS (U.K.) LIMITEDAMERINDO INVESTMENT ADVISORS INCAMERINDO INVESTMENT ADVISORS INC.AMERINDO INVESTMENT ADVISORS INC. PROFIT SHARING TRUSTAMERINDO INVESTMENT ADVISORS, INC., A PANAMA CORPORATIONGARY A. TANAKA
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A 31019
  Complete submission text file 0000860655-96-000077.txt   33364
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-37954 | Film No.: 96599727
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ONE EMBARCADERO CENTER STE 2300 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 2300 SAN FRANCISCO CA 94111 4153620292
AMERINDO INVESTMENT ADVISORS INC (Filed by) CIK: 0000860655 (see all company filings)

IRS No.: 942997472 | State of Incorp.: CA | Fiscal Year End: 0430